Clinician Experience with Using Hypoallergenic Formulas to Treat Infants with Suspected Cow’s Milk Protein Allergy: A Secondary Analysis of a Prospective Survey Cohort
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: Cow’s milk protein allergy (CMPA) is a common condition in infants, but little is known about healthcare providers’ clinical experience treating infants with CMPA. To address this gap, we analyzed prospectively collected data from healthcare providers (HCPs) who treated infants under six months old with suspected CMPA using hypoallergenic formulas. The study focused on a commercial extensively hydrolyzed formula containing Lactobacillus rhamnosus GG (ATCC53103) (eHF-LGG) or a commercial amino acid formula (AAF). Methods: In this secondary analysis of prospectively collected survey data, 52 HCPs treated 329 infants under six months old with suspected CMPA using hypoallergenic formulas. A series of two de-identified surveys per patient were collected by HCPs to assess short-term symptom relief in the patients and HCP’s satisfaction with the management strategies. The initial survey was completed at the initiation of treatment of CMPA, and the second survey was completed at a follow-up visit. Results: The majority of HCPs (87%) in the study were general pediatricians, and most saw 2 to 10 CMPA patients weekly. Results showed that clinicians reported satisfaction with treatment in 95% of patients in the EHF cohort and 97% of patients in the AAF cohort and achieved expected clinical results in 93% and 97% of patients using eHF and AAF, respectively. Furthermore, few patients were switched from the hypoallergenic formula once initiated. Conclusion: The study provides new insights into HCP perspectives on treating infants with CMPA and supports using hypoallergenic formulas to manage this condition. However, additional prospective controlled studies are needed to confirm these initial findings.
Abstract
Purpose: Cow’s milk protein allergy (CMPA) is a common condition in infants, but little is known about healthcare providers’ clinical experience treating infants with CMPA. To address this gap, we analyzed prospectively collected data from healthcare providers (HCPs) who treated infants under six months old with suspected CMPA using hypoallergenic formulas. The study focused on a commercial extensively hydrolyzed formula containing Lactobacillus rhamnosus GG (ATCC53103) (eHF-LGG) or a commercial amino acid formula (AAF). Methods: In this secondary analysis of prospectively collected survey data, 52 HCPs treated 329 infants under six months old with suspected CMPA using hypoallergenic formulas. A series of two de-identified surveys per patient were collected by HCPs to assess short-term symptom relief in the patients and HCP’s satisfaction with the management strategies. The initial survey was completed at the initiation of treatment of CMPA, and the second survey was completed at a follow-up visit. Results: The majority of HCPs (87%) in the study were general pediatricians, and most saw 2 to 10 CMPA patients weekly. Results showed that clinicians reported satisfaction with treatment in 95% of patients in the EHF cohort and 97% of patients in the AAF cohort and achieved expected clinical results in 93% and 97% of patients using eHF and AAF, respectively. Furthermore, few patients were switched from the hypoallergenic formula once initiated. Conclusion: The study provides new insights into HCP perspectives on treating infants with CMPA and supports using hypoallergenic formulas to manage this condition. However, additional prospective controlled studies are needed to confirm these initial findings.
참고문헌 (21)
- Fiocchi A, "Cow’s milk allergy in children and adults", Chem Immunol Allergy, 101, pp.114~123 (2015)
- Hill DJ, "Manifestations of milk allergy in infancy : clinical and immunologic findings", J Pediatr, 109, pp.270~276 (1986)
- Høst A, "A prospective study of cow milk allergy in Danish infants during the first 3 years of life. Clinical course in relation to clinical and immunological type of hypersensitivity reaction", Allergy, 45, pp.587~596 (1990)
- Rona RJ, "The prevalence of food allergy : a meta-analysis", J Allergy Clin Immunol, 120, pp.638~646 (2007)
- Sicherer SH, "Epidemiology of food allergy", J Allergy Clin Immunol, 127, pp.594~602 (2011)
- Warren CM, "The epidemiology of milk allergy in US children", Ann Allergy Asthma Immunol, 110, pp.370~374 (2013)
- Høst A, "Frequency of cow’s milk allergy in childhood", Ann Allergy Asthma Immunol, 89(6 Suppl 1), pp.33~37 (2002)
- Koletzko S, "Diagnostic approach and management of cow’s-milk protein allergy in infants and children : ESPGHAN GI Committee practical guidelines", J Pediatr Gastroenterol Nutr, 55, pp.221~229 (2012)
- Vandenplas Y, "Symptoms, diagnosis, and treatment of cow’s milk allergy", Curr Pediatr Rev, 11, pp.293~297 (2015)
- Guest JF, "Effectiveness of using an extensively hydrolyzed casein formula supplemented with Lactobacillus rhamnosus GG compared with an extensively hydrolysed whey formula in managing cow’s milk protein allergic infants", J Comp Eff Res, 8, pp.1317~1326 (2019)
- Vandenplas Y, "Prevention and management of cow’s milk allergy in non-exclusively breastfed infants", Nutrients, 9, pp.731~ (2017)
- Fiocchi A, "World allergy organization(WAO)diagnosis and rationale for action against cow’s milk allergy(DRACMA)guidelines", Pediatr Allergy Immunol, 21(Suppl 21), pp.1~125 (2010)
- Caffarelli C, "Cow’s milk protein allergy in children : a practical guide", Ital J Pediatr, 36, pp.5~ (2010)
- Vandenplas Y, "Current guidelines and future strategies for the management of cow’s milk allergy", J Asthma Allergy, 14, pp.1243~1256 (2021)
- Meyer R, "When should infants with cow’s milk protein allergy use an amino acid formula? a practical guide", J Allergy Clin Immunol Pract, 6, pp.383~399 (2018)
- Berni Canani R, "Effect of Lactobacillus GG on tolerance acquisition in infants with cow’s milk allergy : a randomized trial", J Allergy Clin Immunol, 129, pp.582 e1~582 e5 (2012)
- Berni Canani R, "Formula selection for management of children with cow’s milk allergy influences the rate of acquisition of tolerance : a prospective multicenter study", J Pediatr, 163, pp.771~777 (2013)[DOI]
- Lozinsky AC, "Cow’s milk protein allergy from diagnosis to management : a very different journey for general practitioners and parents", Children(Basel), 2, pp.317~329 (2015)
- Wilsey MJ, "Extensively hydrolyzed formula improves allergic symptoms in the short term in infants with suspected cow’s milk protein allergy", Nutrients, 15, pp.1677~ (2023)
- Wilsey MJ, "Short-term symptom improvement in infants with suspected cow’s milk protein allergy using amino acid formula : a prospective cohort analysis", Front Nutr, 10, pp.1208334~ (2023)
- Ludman S, "Managing cows’ milk allergy in children", BMJ, 347, pp.f5424~ (2013)